Efficient approach to prepare multiple chemotherapeutic agent conjugated nanocarrier
Vijayakameswara Rao N1, Himadri Dinda, Mutyala Naidu Ganivada
1Polymer Research Centre, Department of Chemical Sciences, Indian Institute of Science Education and Research Kolkata, India. sraja@iiserkol.ac.in.
Summary
A novel pH-responsive nanocarrier delivers multiple cancer drugs, doxorubicin and indomethacin, for combination chemotherapy. This folate-conjugated norbornene polymer shows promise for targeted cancer treatment.
Area of Science:
- Polymer Chemistry
- Nanotechnology
- Drug Delivery
Background:
- Developing effective drug delivery systems is crucial for improving cancer chemotherapy outcomes.
- pH-responsive nanocarriers offer potential for targeted drug release in tumor microenvironments.
- Combination chemotherapy using multiple agents can overcome drug resistance and enhance efficacy.
Purpose of the Study:
- To synthesize and characterize a novel pH-responsive, multi-drug nanocarrier for combination cancer chemotherapy.
- To conjugate doxorubicin, indomethacin, and folate to a norbornene polymer backbone.
- To evaluate the chemical and biological properties of the developed nanocarrier.
Main Methods:
- Synthesis of a norbornene polymer backbone.
- Conjugation of doxorubicin and indomethacin via ester linkers for pH-responsiveness.
- Attachment of folate for targeted delivery.
- Characterization of chemical and biological properties.
Main Results:
- Successful synthesis of a pH-responsive, multi-drug norbornene-based polymeric nanocarrier.
- Demonstration of drug conjugation via pH-sensitive ester linkers.
- Characterization of the nanocarrier's chemical and biological attributes.
Conclusions:
- The novel norbornene-based nanocarrier is a promising platform for pH-responsive, combination cancer chemotherapy.
- The system allows for targeted delivery and controlled release of multiple chemotherapeutic agents.
- Further studies are warranted to explore its in vivo efficacy and therapeutic potential.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
148
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
148
Modified-Release Drug Delivery Systems: Site-Targeted
160
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
160


